nih glp 1 GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Can GLP-1s prevent Alzheimer's? NIH-funded
Description
This is the most commonly cited mechanism and arguably the most plausible
[DOI] [PubMed] [Google Scholar] 424.Zhang Y., Sun B., Feng D., Hu H., Chu M., Qu Q
severe dehydration is rare in outpatient weight loss treatment but can worsen constipation and trigger dizziness
Emerging oral and long-acting formulations may overcome barriers to self-injection in frail or cognitively impaired populations
Diabetic agents, from metformin to SGLT2 inhibitors and GLP1 receptor agonists: JACC focus seminar
